The Korean Society of Cardiology Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2017
NCT04646278
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

The Korean Society of Cardiology

Active Ingredients

Drugs in Other Trials (1)

nicorandil (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1